RABV has evolved different mechanisms to bypass the immune response, such as inhibiting IFN production and suppressing major histocompatibility complex (MHC) and IFN synthesis in dendritic cells (DCs) after infection [16]. This evidence concerns the gene IFNA1 and infection.